158 related articles for article (PubMed ID: 37082811)
1. DNA methyltransferase expression (DNMT1, DNMT3a and DNMT3b) as a potential biomarker for anti-VEGF diabetic macular edema response.
Camacho P; Ribeiro E; Pereira B; Varandas T; Nascimento J; Henriques J; Dutra-Medeiros M; Delgadinho M; Oliveira K; Silva C; Brito M
Eur J Ophthalmol; 2023 Nov; 33(6):2267-2274. PubMed ID: 37082811
[TBL] [Abstract][Full Text] [Related]
2. Fundus microperimetry patterns of fixation in type 2 diabetic patients with diffuse macular edema.
Carpineto P; Ciancaglini M; Di Antonio L; Gavalas C; Mastropasqua L
Retina; 2007 Jan; 27(1):21-9. PubMed ID: 17218911
[TBL] [Abstract][Full Text] [Related]
3. [Correlation of retinal sensitivity, visual acuity and central macular thickness in different types of diabetic macular edema].
Yang XL; Zou HD; Xu X
Zhonghua Yan Ke Za Zhi; 2013 Dec; 49(12):1081-8. PubMed ID: 24499694
[TBL] [Abstract][Full Text] [Related]
4. Treatment results of diabetic macular edema with different choroidal thickness with intravitreal anti vascular endothelial growth factor.
Savur F; Kaldırım H; Atalay K; Öğreden T; Hayat ŞÇ
BMC Ophthalmol; 2022 Dec; 22(1):508. PubMed ID: 36550418
[TBL] [Abstract][Full Text] [Related]
5. [Neurodegenerative biomarkers of the response to diabetic macular edema treatment].
Petrachkov DV; Budzinskaya MV; Pavlov VG; Durzhinskaya MH; Khalatyan AS
Vestn Oftalmol; 2020; 136(4. Vyp. 2):201-206. PubMed ID: 32880140
[TBL] [Abstract][Full Text] [Related]
6. Changes in choroidal thickness after anti-vascular endothelial growth factor treatment of diabetic macular edema, real-life data, 2-year results.
Savur F; Kaldırım H; Atalay K; Korkmaz Ş
Cutan Ocul Toxicol; 2021 Dec; 40(4):326-331. PubMed ID: 34275395
[TBL] [Abstract][Full Text] [Related]
7. The impact of metabolic parameters on clinical response to VEGF inhibitors for diabetic macular edema.
Matsuda S; Tam T; Singh RP; Kaiser PK; Petkovsek D; Carneiro G; Zanella MT; Ehlers JP
J Diabetes Complications; 2014; 28(2):166-70. PubMed ID: 24374138
[TBL] [Abstract][Full Text] [Related]
8. MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.
Santos AR; Alves D; Santos T; Figueira J; Silva R; Cunha-Vaz JG
Retina; 2019 Jan; 39(1):52-60. PubMed ID: 29077605
[TBL] [Abstract][Full Text] [Related]
9. Behavior of SD-OCT-detected hyperreflective foci in the retina of anti-VEGF-treated patients with diabetic macular edema.
Framme C; Schweizer P; Imesch M; Wolf S; Wolf-Schnurrbusch U
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5814-8. PubMed ID: 22836760
[TBL] [Abstract][Full Text] [Related]
10. Correlation of retinal layer changes with vision gain in diabetic macular edema during conbercept treatment.
Xu Y; Qu Y; Suo Y; Gao J; Chen X; Liu K; Xu X
BMC Ophthalmol; 2019 May; 19(1):123. PubMed ID: 31151389
[TBL] [Abstract][Full Text] [Related]
11. [First experiences with Navilas® 577s micropulse laser in the treatment of diabetic maculopathy].
Ecsedy M; Kovács I; Gergely R; Gombos K; Meisel J; Kovács A; Czakó C; Nagy ZZ
Orv Hetil; 2020 Dec; 161(49):2078-2085. PubMed ID: 33279883
[TBL] [Abstract][Full Text] [Related]
12. Relationship of macular microcirculation and retinal thickness with visual acuity in diabetic macular edema.
Sakata K; Funatsu H; Harino S; Noma H; Hori S
Ophthalmology; 2007 Nov; 114(11):2061-9. PubMed ID: 17445900
[TBL] [Abstract][Full Text] [Related]
13. A real-world study for timely assessing the diabetic macular edema refractory to intravitreal anti-VEGF treatment.
Hsieh TC; Deng GH; Chang YC; Chang FL; He MS
Front Endocrinol (Lausanne); 2023; 14():1108097. PubMed ID: 37265702
[TBL] [Abstract][Full Text] [Related]
14. Flavoprotein Fluorescence Correlation with Visual Acuity Response in Patients Receiving Anti-VEGF Injection for Diabetic Macular Edema.
Andrade Romo JS; Lynch G; Liu K; Kim D; Jansen M; Field MG; Elner VM; Rosen RB
Oxid Med Cell Longev; 2018; 2018():3567306. PubMed ID: 30159113
[TBL] [Abstract][Full Text] [Related]
15. Multifocal electroretinogram in diabetic macular edema and its correlation with different optical coherence tomography features.
Khojasteh H; Riazi-Esfahani H; Khalili Pour E; Faghihi H; Ghassemi F; Bazvand F; Mahmoudzadeh R; Salabati M; Mirghorbani M; Riazi Esfahani M
Int Ophthalmol; 2020 Mar; 40(3):571-581. PubMed ID: 31712927
[TBL] [Abstract][Full Text] [Related]
16. Effect of anti-vascular endothelial growth factor therapy on choroidal thickness in diabetic macular edema.
Yiu G; Manjunath V; Chiu SJ; Farsiu S; Mahmoud TH
Am J Ophthalmol; 2014 Oct; 158(4):745-751.e2. PubMed ID: 24952275
[TBL] [Abstract][Full Text] [Related]
17. Retinal thickness measurement and evaluation of natural history of the diabetic macular edema through optical coherence tomography.
Hannouche RZ; Avila MP
Arq Bras Oftalmol; 2009; 72(4):433-8. PubMed ID: 19820779
[TBL] [Abstract][Full Text] [Related]
18. The area of fixation covaries with short-term changes in visual acuity after anti-vascular endothelial growth factor treatment in patients with diabetic macular oedema.
Jakobsen NS; Larsen DA; Bek T
Acta Ophthalmol; 2018 Nov; 96(7):744-748. PubMed ID: 29687595
[TBL] [Abstract][Full Text] [Related]
19. Short-term outcomes of intravitreal dexamethasone in relation to biomarkers in diabetic macular edema.
Narnaware SH; Bawankule PK; Raje D
Eur J Ophthalmol; 2021 May; 31(3):1185-1191. PubMed ID: 32429696
[TBL] [Abstract][Full Text] [Related]
20. Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT.
Lois N; Campbell C; Waugh N; Azuara-Blanco A; Maredza M; Mistry H; McAuley D; Acharya N; Aslam TM; Bailey C; Chong V; Downey L; Eleftheriadis H; Fatum S; George S; Ghanchi F; Groppe M; Hamilton R; Menon G; Saad A; Sivaprasad S; Shiew M; Steel DH; Talks JS; Doherty P; McDowell C; Clarke M
Health Technol Assess; 2022 Dec; 26(50):1-86. PubMed ID: 36541393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
